UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: March 22, 1996
Mycogen Corporation
-------------------
(Exact name of registrant as specified in its charter)
California 0-15881 95-3802654
---------- ------- ----------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
5501 Oberlin Drive, San Diego, California, 92121
------------------------------------------------
(Address of principal executive offices)
Registrant's telephone number, including area code: 619-453-8030
Not Applicable
--------------
(Former name or former address, if changed since last report.)
ITEMS 1. - 4. Not applicable.
ITEM 5. OTHER EVENTS.
The Registrant's Amended and Restated Rights Agreement by and between Registrant
and Bank of Boston and filed on November 28, 1995, as an exhibit to the
Registrant's Form 8-K and incorporated herein by this reference, was amended by
that certain Amendment No. 1 to Amended and Restated Rights Agreement which
deleted all references to The Lubrizol Corporation.
ITEM 6. Not applicable.
1
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(a) Not applicable.
(b) Not applicable.
(c) Exhibits.
----------
Exhibit Number Description
-------------- -----------
4.1 Amendment No. 1 to Amended and Restated Rights Agreement.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Mycogen Corporation
-------------------
(Registrant)
Date: March 22, 1996 /s/ James A. Baumker
-------------- ----------------------
James A. Baumker
Vice President,
Chief Financial Officer,
Chief Accounting Officer
2